Primidone Tablet
Product Images NDC 53746-545

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Primidone (NDC 53746-545). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Amneal Pharmaceuticals Of New York Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

36e4a4a6-figure-01 (Primidone Tablets Usp 1)

This text indicates the chemical formula and molecular weight of CoHNO, which is a type of chemical compound. It does not provide any further information beyond that.*

FDA Label Image

36e4a4a6-figure-02 (Primidone Tablets Usp 2)

This is a table showing the risks associated with the use of antiepileptic drugs, categorized by indication. The table shows the number of patients taking a placebo versus the number taking the drug, the relative risk, and the incidence of events. The indications include epilepsy, psychiatric, and other. The total number of patients is 43, and the incidence rate in the drug group is slightly higher than that in the placebo group.*

FDA Label Image

36e4a4a6-figure-03 (Primidone Tablets Usp 3)

FDA Label Image

50mg_100tab (Primidone Tablets Usp 4)

FDA Label Image

250mg_100tab (Primidone Tablets Usp 5)

Print Medication Guide can be found at DC 53746-545-01. A QR code is also provided to access the guide online. The text mentions a medication called Primidone in the form of tablets. Pharmacists are advised to dispense the Medication Guide to each patient.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.